SMTL ID : 9fjt.1

Human Monoamine Oxidase B in complex with MC4762 inhibitor (9a) at 1.4 A resolution

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.40 Å

Oligo State

homo-dimer

Ligands

2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Covalent)

FAD.1: 36 residues within 4Å: Chain A: V.10, G.11, G.12, G.13, I.14, S.15, L.33, E.34, A.35, R.36, G.40, G.41, R.42, T.43, L.56, G.57, G.58, S.59, Y.60, R.233, P.234, V.235, A.263, I.264, P.265, W.388, Y.393, C.397, Y.398, G.425, T.426, G.434, Y.435, M.436, A.439 Ligands: 01.3 30 PLIP interactions: 30 interactions with chain A Hydrophobic interactions: A:W.388, A:Y.398, A:Y.398 Hydrogen bonds: A:G.13, A:S.15, A:A.35, A:R.36, A:R.42, A:G.58, A:S.59, A:Y.60, A:Y.60, A:V.235, A:V.235, A:T.426, A:T.426, A:G.434, A:M.436 Water bridges: A:I.14, A:G.16, A:E.34, A:E.34, A:R.42, A:R.42, A:T.43, A:Q.65, A:E.437 Salt bridges: A:R.42, A:R.42 pi-Stacking: A:Y.393 FAD.4: 35 residues within 4Å: Chain B: V.10, G.11, G.12, G.13, I.14, S.15, L.33, E.34, A.35, R.36, G.40, G.41, R.42, T.43, G.57, G.58, S.59, Y.60, R.233, P.234, V.235, A.263, I.264, P.265, W.388, Y.393, C.397, Y.398, G.425, T.426, G.434, Y.435, M.436, A.439 Ligands: 01.6 30 PLIP interactions: 30 interactions with chain B Hydrophobic interactions: B:W.388, B:Y.398, B:Y.398 Hydrogen bonds: B:G.12, B:G.13, B:S.15, B:A.35, B:R.36, B:R.42, B:G.58, B:S.59, B:Y.60, B:Y.60, B:V.235, B:V.235, B:T.426, B:G.434, B:M.436 Water bridges: B:I.14, B:G.16, B:E.34, B:G.41, B:R.42, B:R.42, B:T.43, B:Q.65, B:E.437 Salt bridges: B:R.42, B:R.42 pi-Stacking: B:Y.393

2 x C15: N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE(Non-covalent)

C15.2: 4 residues within 4Å: Chain A: D.153, K.154, C.156, W.157 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:W.157, A:W.157 Water bridges: A:K.154 pi-Cation interactions: A:W.157, A:W.157 C15.5: 4 residues within 4Å: Chain B: D.153, K.154, C.156, W.157 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:W.157 Water bridges: B:K.154 pi-Cation interactions: B:W.157, B:W.157

2 x 01: ~{N}-[[4-[[7-(1,3-benzoxazol-2-ylsulfanyl)-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]methyl]phenyl]methyl]-~{N}-methyl-prop-2-yn-1-amine

01.3: 15 residues within 4Å: Chain A: P.102, P.104, W.119, L.164, F.168, L.171, C.172, I.198, I.199, Q.206, I.316, Y.326, Y.398, Y.435 Ligands: FAD.1 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.171, A:L.171, A:Y.326, A:Y.398 Hydrogen bonds: A:I.199 01.6: 17 residues within 4Å: Chain B: P.102, F.103, P.104, W.119, L.164, F.168, L.171, C.172, I.198, I.199, Q.206, I.316, Y.326, F.343, Y.398, Y.435 Ligands: FAD.4 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:F.103, B:W.119, B:W.119, B:L.171, B:L.171, B:Y.326, B:F.343, B:Y.398 pi-Stacking: B:W.119, B:W.119

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Noce, B. et al., Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor. J.Med.Chem. (2025)

Release Date

2025-03-12

Peptides

Amine oxidase [flavin-containing] B: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

B
BBB

Amine oxidase [flavin-containing] B

Related Entries With Identical Sequence